1.
Clin Invest Med
; 6(1): 1-4, 1983.
Article
in English
| MEDLINE
| ID: mdl-6339131
Subject(s)
Bacterial Infections/immunology , Uremia/immunology , Animals , Bacterial Infections/etiology , Disease Models, Animal , Humans , Immune Tolerance , Immunity, Cellular , Immunity, Innate , Immunocompetence , Immunosuppressive Agents/pharmacology , Kidney Failure, Chronic/complications , Uremia/complications
2.
Am J Med
; 71(3): 334-6, 1981 Sep.
Article
in English
| MEDLINE
| ID: mdl-6456663
Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/immunology , Immunosuppression Therapy , Nephritis/immunology , Animals , Bacterial Infections/drug therapy , Drug Synergism , Humans , Immunity, Cellular/drug effects , Immunosuppressive Agents/pharmacology , Nephritis/drug therapy , T-Lymphocytes, Regulatory/drug effects
3.
J Biol Chem
; 252(23): 8423-7, 1977 Dec 10.
Article
in English
| MEDLINE
| ID: mdl-925002
ABSTRACT
A search for the source of the residual esterase activity of crude lima bean protease inhibitor-binding anhydrochymotrypsin preparations was undertaken. The preparations were found to contain about 40% of protein that possesses 1% (kc/Km) to 12% (kc) of the esterase activity of alpha-chymotrypsin. The active protein was isolated by affinity chromatography on soybean trypsin inhibitor-Sepharose. It appears to be an anhydroenzyme or a mixture of a limited number of anhydroenzymes in which a serine other than the catalytically essential serine-195 of the native enzyme has been converted to dehydroalanine.
